Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Ellyn Witt

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Nursing|March 17, 2004
Understanding stereotactic radiosurgery for intracranial tumors, seed implants for prostate cancer, and intravascular brachytherapy for cardiac restenosisMary Ellyn Witt, Marilyn Haas, Marie A Marrinan, et al.
Head & Neck|June 15, 2013
Lymph node density--prognostic value in head and neck cancerSonali Rudra, Michael T Spiotto, Mary Ellyn Witt, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancerJoseph K Salama, Daniel J Haraf, Kerstin Stenson, et al.
Journal of Geriatric Oncology|January 30, 2014
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapyRonald J Maggiore, Emily K Curran, Mary Ellyn Witt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2010
Chemoreirradiation for recurrent salivary gland malignanciesAaron W Pederson, Daniel J Haraf, Elizabeth A Blair, et al.
Head & Neck|February 27, 2010
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongueAaron W Pederson, Daniel J Haraf, Mary-Ellyn Witt, et al.
International Journal of Radiation Oncology, Biology, Physics|October 11, 2005
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinomaJoseph K Salama, Everett E Vokes, Steven J Chmura, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2010
Outcomes in black patients with early breast cancer treated with breast conservation therapyMichael A Nichols, Loren K Mell, Michael D Hasselle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2010
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancerKevin S Choe, Joseph K Salama, Kerstin M Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neckMichael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Nursing|March 17, 2004
Understanding stereotactic radiosurgery for intracranial tumors, seed implants for prostate cancer, and intravascular brachytherapy for cardiac restenosisMary Ellyn Witt, Marilyn Haas, Marie A Marrinan, et al.
Head & Neck|June 15, 2013
Lymph node density--prognostic value in head and neck cancerSonali Rudra, Michael T Spiotto, Mary Ellyn Witt, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancerJoseph K Salama, Daniel J Haraf, Kerstin Stenson, et al.
Journal of Geriatric Oncology|January 30, 2014
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapyRonald J Maggiore, Emily K Curran, Mary Ellyn Witt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 14, 2010
Chemoreirradiation for recurrent salivary gland malignanciesAaron W Pederson, Daniel J Haraf, Elizabeth A Blair, et al.
Head & Neck|February 27, 2010
Chemoradiotherapy for locoregionally advanced squamous cell carcinoma of the base of tongueAaron W Pederson, Daniel J Haraf, Mary-Ellyn Witt, et al.
International Journal of Radiation Oncology, Biology, Physics|October 11, 2005
Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinomaJoseph K Salama, Everett E Vokes, Steven J Chmura, et al.
International Journal of Radiation Oncology, Biology, Physics|May 4, 2010
Outcomes in black patients with early breast cancer treated with breast conservation therapyMichael A Nichols, Loren K Mell, Michael D Hasselle, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2010
Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancerKevin S Choe, Joseph K Salama, Kerstin M Stenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2004
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neckMichael T Milano, Daniel J Haraf, Kerstin M Stenson, et al.
Pageof 3